Fredun Pharmaceuticals allots 44,000 equity shares on conversion of warrants

Fredun Pharmaceuticals has allotted 44,000 equity shares to non-promoter allottees pursuant to conversion of 14,667 warrants into equity shares, consequent to the 1:2 bonus issue.